CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

Inflation and the Covid-19 pandemic have put pharmaceutical productivity front and center in recent years. Thus, drug companies are under mounting pressure to prove that new treatments are safe and ...

This study is led by Dr. Nan Qiao (Laboratory of Health Intelligence, Huawei Cloud Computing Technologies), Dr. Hualiang Jiang (Shanghai Institute of Materia Medica, Chinese Academy of Sciences) and ...

UnitedHealth-owned Optum Rx, one of the biggest pharmacy benefit managers in the U.S., is launching a new drug pricing model next year meant to make payers’ spending on pharmaceuticals more ...

Researchers at the CUNY Graduate Center have created an artificial intelligence model, Context-aware Deconfounding Autoencoder (CODE-AE), that can screen drug compounds to accurately predict efficacy ...

The Biden administration is proposing rescinding a Trump-era model that ties Medicare Part B drugs and biologicals to the lowest price that drug manufacturers receive in other wealthy countries. Known ...